Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ21062 Activators

FLJ21062 activators belong to a unique class of chemical compounds that are characterized by their ability to modulate the function of the protein encoded by the FLJ21062 gene. The FLJ21062 gene, like many genes within the human genome, encodes a protein whose function may not be fully elucidated but is believed to play a role in cellular processes. The activators designed to target this gene product are formulated based on the understanding of the protein's structure and the biological pathway it may be involved in. These molecules can be small organic compounds, peptides, or other bioactive agents that have the capacity to interact with the protein, resulting in an increase in its activity. The chemical structure of these activators is often complex, reflecting the specificity required to engage with the unique sites on the protein target.

The development and study of FLJ21062 activators necessitate advanced understanding of biochemistry and molecular biology. The interaction between the activators and the FLJ21062 protein is typically mediated through a binding event that leads to a conformational change in the protein, enhancing its natural activity. The specificity of these interactions is critical, as off-target effects can lead to undesired outcomes. Therefore, the activators are often optimized through a meticulous process of chemical modification and structure-activity relationship studies. This optimization process involves altering chemical groups within the activator molecule to improve its binding affinity and selectivity for the FLJ21062 protein. The precise mechanism by which these activators exert their effect on the protein's function is a subject of rigorous research, often involving techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and various computational methods to model the interactions at an atomic level. Through such detailed analyses, researchers aim to unravel the complexities of the protein's activation and regulation, which is intrinsic to the understanding of the intricate web of cellular pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin is a diterpene that directly stimulates adenylate cyclase, leading to increased levels of cyclic AMP (cAMP) in cells. Elevated cAMP can enhance FLJ21062 activity by activating protein kinase A (PKA), which may phosphorylate and regulate proteins that interact with or modulate FLJ21062 function.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins that are involved in the same signaling pathways or cellular processes as FLJ21062, indirectly enhancing its functional activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways. These pathways can subsequently influence the activity of FLJ21062 through calcium-dependent kinases or phosphatases.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a polyphenol found in green tea with kinase inhibitory activity. By inhibiting certain kinases, EGCG may reduce negative regulatory influences on pathways that FLJ21062 is part of, thus potentially enhancing FLJ21062 functional activity.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

S1P is a bioactive lipid that binds to G protein-coupled receptors, leading to activation of downstream signaling cascades. Such cascades can include the activation of kinases or secondary messengers that modulate the pathways involving FLJ21062, leading to its enhanced activity.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is a pyrrolidine antibiotic that acts as a protein synthesis inhibitor and activator of stress-activated protein kinases. This can lead to a cellular stress response that might enhance the activity of FLJ21062 if it is involved in cellular stress or repair pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can alter downstream signaling pathways, such as the AKT signaling pathway, which may indirectly enhance the functional activity of FLJ21062 by altering the cellular context in which FLJ21062 operates.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP is a cell-permeable cAMP analog. It activates cAMP-dependent pathways, such as PKA signaling, which can lead to changes in protein phosphorylation states and enhance the activity of FLJ21062 by similar mechanisms as Forskolin.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is an ionophore that selectively transports calcium across cell membranes. By increasing intracellular calcium, it activates calcium-dependent enzymes and signaling pathways, potentially enhancing the functional activity of FLJ21062.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases leads to increased phosphorylation of cellular proteins, which can indirectly enhance the activity of FLJ21062 if it is regulated by phosphorylation.